{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:46:59Z","timestamp":1761094019722,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.7759\/cureus.95057","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:53Z","timestamp":1761056693000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypercalcemia in Patients After Kidney Transplantation"],"prefix":"10.7759","author":[{"given":"Mi\u0142osz","family":"Miedziaszczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Lacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Bajon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Kamalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Zelga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Swiatek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Karczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Idasiak-Piechocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X202010558","article-title":"Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others","volume":"54","author":"Moyses-Neto M","year":"2021","unstructured":"Moyses-Neto M, Garcia TM, Nardin ME, Muglia VA, Molina CA, Romao EA. Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others. Braz J Med Biol Res. 2021, 54:e10558. 10.1590\/1414-431X202010558","journal-title":"Braz J Med Biol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12291","article-title":"Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice","volume":"28","author":"Muirhead N","year":"2014","unstructured":"Muirhead N, Zaltman JS, Gill JS, Churchill DN, Poulin-Costello M, Mann V, Cole EH. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant. 2014, 28:161-5. 10.1111\/ctr.12291","journal-title":"Clin Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.12.050","article-title":"Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation","volume":"44","author":"Kim YJ","year":"2012","unstructured":"Kim YJ, Kim MG, Jeon HJ, et al.. Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation. Transplant Proc. 2012, 44:651-6. 10.1016\/j.transproceed.2011.12.050","journal-title":"Transplant Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00837-0","article-title":"Bone mineral disease after kidney transplantation","volume":"108","author":"Torregrosa JV","year":"2021","unstructured":"Torregrosa JV, Ferreira AC, Cucchiari D, Ferreira A. Bone mineral disease after kidney transplantation. Calcif Tissue Int. 2021, 108:551-60. 10.1007\/s00223-021-00837-0","journal-title":"Calcif Tissue Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2019.1655233","article-title":"Hypercalcemia associated with Pneumocystis jirovecii pneumonia in renal transplant recipients: case report and literature review","volume":"76","author":"Coche S","year":"2021","unstructured":"Coche S, Cornet G, Morelle J, Labriola L, Kanaan N, Demoulin N. Hypercalcemia associated with Pneumocystis jirovecii pneumonia in renal transplant recipients: case report and literature review. Acta Clin Belg. 2021, 76:75-8. 10.1080\/17843286.2019.1655233","journal-title":"Acta Clin Belg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.11.004","article-title":"Iatrogenic hypercalcemia postrenal transplantation","volume":"4","author":"Kelly YP","year":"2019","unstructured":"Kelly YP, Onuchic-Whitford A, Rosales IA, Williams WW. Iatrogenic hypercalcemia postrenal transplantation. Kidney Int Rep. 2019, 4:487-90. 10.1016\/j.ekir.2018.11.004","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5935\/0101-2800.20160074","article-title":"Hypercalcemia and renal function impairment associated with vitamin D toxicity: case report","volume":"38","author":"Guerra V","year":"2016","unstructured":"Guerra V, Neto OM, Laurindo AF, de Paula FJ, Neto MM. Hypercalcemia and renal function impairment associated with vitamin D toxicity: case report. J Bras Nefrol. 2016, 38:466-9. 10.5935\/0101-2800.20160074","journal-title":"J Bras Nefrol"},{"key":"ref8","article-title":"Brenner and Rector's The Kidney, Tenth Edition","author":"Skorecki K","year":"2016","unstructured":"Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu AS. Brenner and Rector's The Kidney, Tenth Edition. Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu AS (ed): Elsevier, Philadelphia, PA; 2016."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.12.065","article-title":"Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients","volume":"38","author":"Ozdemir FN","year":"2006","unstructured":"Ozdemir FN, Afsar B, Akgul A, Usluo\u011fullari C, Ak\u00e7ay A, Haberal M. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc. 2006, 38:480-2. 10.1016\/j.transproceed.2005.12.065","journal-title":"Transplant Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1391-z","article-title":"The effect of hypercalcemia on allograft calcification after kidney transplantation","volume":"48","author":"\u00c7eltik A","year":"2016","unstructured":"\u00c7eltik A, \u015een S, Y\u0131lmaz M, et al.. The effect of hypercalcemia on allograft calcification after kidney transplantation. Int Urol Nephrol. 2016, 48:1919-25. 10.1007\/s11255-016-1391-z","journal-title":"Int Urol Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000110875","article-title":"Abnormal bone and mineral metabolism in kidney transplant patients--a review","volume":"28","author":"Sprague SM","year":"2008","unstructured":"Sprague SM, Belozeroff V, Danese MD, Martin LP, Olgaard K. Abnormal bone and mineral metabolism in kidney transplant patients--a review. Am J Nephrol. 2008, 28:246-53. 10.1159\/000110875","journal-title":"Am J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.09.030","article-title":"Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study","volume":"43","author":"Van de Cauter J","year":"2011","unstructured":"Van de Cauter J, Sennesael J, Haentjens P. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study. Transplant Proc. 2011, 43:3470-5. 10.1016\/j.transproceed.2011.09.030","journal-title":"Transplant Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00306.x","article-title":"A prospective randomized study for prevention of postrenal transplantation bone loss","volume":"67","author":"El-Agroudy AE","year":"2005","unstructured":"El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA. A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int. 2005, 67:2039-45. 10.1111\/j.1523-1755.2005.00306.x","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.07.087","article-title":"1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation","volume":"41","author":"Falkiewicz K","year":"2009","unstructured":"Falkiewicz K, Boratynska M, Speichert-Bidzi\u0144ska B, Magott-Procelewska M, Biecek P, Patrzalek D, Klinger M. 1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation. Transplant Proc. 2009, 41:3002-5. 10.1016\/j.transproceed.2009.07.087","journal-title":"Transplant Proc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00618.x","article-title":"A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents","volume":"4","author":"El-Husseini AA","year":"2004","unstructured":"El-Husseini AA, El-Agroudy AE, El-Sayed M, Sobh MA, Ghoneim MA. A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents. Am J Transplant. 2004, 4:2052-7. 10.1111\/j.1600-6143.2004.00618.x","journal-title":"Am J Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4469","article-title":"Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: a prespecified secondary endpoint analysis of a randomized controlled trial","volume":"37","author":"Tsujita M","year":"2022","unstructured":"Tsujita M, Doi Y, Obi Y, et al.. Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: a prespecified secondary endpoint analysis of a randomized controlled trial. J Bone Miner Res. 2022, 37:303-11. 10.1002\/jbmr.4469","journal-title":"J Bone Miner Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000446863","article-title":"Vitamin D in kidney transplant recipients: mechanisms and therapy","volume":"43","author":"Cianciolo G","year":"2016","unstructured":"Cianciolo G, Galassi A, Capelli I, Angelini ML, La Manna G, Cozzolino M. Vitamin D in kidney transplant recipients: mechanisms and therapy. Am J Nephrol. 2016, 43:397-407. 10.1159\/000446863","journal-title":"Am J Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_10.10","article-title":"Vitamin D analogues for secondary hyperparathyroidism","volume":"17","author":"Brown AJ","year":"2002","unstructured":"Brown AJ, Dusso AS, Slatopolsky E. Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant. 2002, 17:10-9. 10.1093\/ndt\/17.suppl_10.10","journal-title":"Nephrol Dial Transplant"},{"key":"ref19","article-title":"Long-term effects of 1 alpha-hydroxycholecalciferol therapy in chronic hemodialysis patients","volume":"18","author":"Rubinger D","year":"1982","unstructured":"Rubinger D, Friedlaender MM, Bernheim J, Shachner E, Ronen M, Czaczkes WJ. Long-term effects of 1 alpha-hydroxycholecalciferol therapy in chronic hemodialysis patients. Isr J Med Sci. 1982, 18:1019-26.","journal-title":"Isr J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone\u00a0Disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone\u00a0Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017, 7:1-59. 10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00087.x","article-title":"Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study","volume":"67","author":"Schwarz A","year":"2005","unstructured":"Schwarz A, Mengel M, Gwinner W, Radermacher J, Hiss M, Kreipe H, Haller H. Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int. 2005, 67:341-8. 10.1111\/j.1523-1755.2005.00087.x","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202201_27773","article-title":"A systematic review of the pharmacotherapy of secondary hyperparathyroidism (SHPT) in grades 3-5 Chronic Kidney Disease (CKD)","volume":"26","author":"Miedziaszczyk M","year":"2022","unstructured":"Miedziaszczyk M, Idasiak-Piechocka I, Wi\u015bniewski OW, Lacka K. A systematic review of the pharmacotherapy of secondary hyperparathyroidism (SHPT) in grades 3-5 Chronic Kidney Disease (CKD). Eur Rev Med Pharmacol Sci. 2022, 26:232-9. 10.26355\/eurrev_202201_27773","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010025","article-title":"Systematic review of the treatment of persistent hyperparathyroidism following kidney transplantation","volume":"11","author":"Miedziaszczyk M","year":"2022","unstructured":"Miedziaszczyk M, Lacka K, Tomczak O, Bajon A, Primke M, Idasiak-Piechocka I. Systematic review of the treatment of persistent hyperparathyroidism following kidney transplantation. Biomedicines. 2022, 11:25. 10.3390\/biomedicines11010025","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423485-hypercalcemia-in-patients-after-kidney-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:54Z","timestamp":1761056694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423485-hypercalcemia-in-patients-after-kidney-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.95057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}